186 related articles for article (PubMed ID: 28867658)
1. Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays.
de Medeiros AS; Wyman AR; Alaamery MA; Allain C; Ivey FD; Wang L; Le H; Morken JP; Habara A; Le C; Cui S; Lerner A; Hoffman CS
Cell Signal; 2017 Dec; 40():73-80. PubMed ID: 28867658
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
Zhang L; Murray F; Zahno A; Kanter JR; Chou D; Suda R; Fenlon M; Rassenti L; Cottam H; Kipps TJ; Insel PA
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19532-7. PubMed ID: 19033455
[TBL] [Abstract][Full Text] [Related]
4. New classes of PDE7 inhibitors identified by a fission yeast-based HTS.
Alaamery MA; Wyman AR; Ivey FD; Allain C; Demirbas D; Wang L; Ceyhan O; Hoffman CS
J Biomol Screen; 2010 Apr; 15(4):359-67. PubMed ID: 20228279
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
[TBL] [Abstract][Full Text] [Related]
6. A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition.
Demirbas D; Wyman AR; Shimizu-Albergine M; Cakici O; Beavo JA; Hoffman CS
PLoS One; 2013; 8(8):e71279. PubMed ID: 23967182
[TBL] [Abstract][Full Text] [Related]
7. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
8. Development of a fission yeast-based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases.
Ivey FD; Wang L; Demirbas D; Allain C; Hoffman CS
J Biomol Screen; 2008 Jan; 13(1):62-71. PubMed ID: 18227226
[TBL] [Abstract][Full Text] [Related]
9. Use of a Fission Yeast Platform to Identify and Characterize Small Molecule PDE Inhibitors.
Hoffman CS
Front Pharmacol; 2021; 12():833156. PubMed ID: 35111072
[TBL] [Abstract][Full Text] [Related]
10. Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.
Vigone G; Shuhaibar LC; Egbert JR; Uliasz TF; Movsesian MA; Jaffe LA
Endocrinology; 2018 May; 159(5):2142-2152. PubMed ID: 29608743
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs.
Mokry J; Joskova M; Mokra D; Christensen I; Nosalova G
Adv Exp Med Biol; 2013; 756():57-64. PubMed ID: 22836619
[TBL] [Abstract][Full Text] [Related]
12. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Kim DH; Lerner A
Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells.
Dong H; Zitt C; Auriga C; Hatzelmann A; Epstein PM
Biochem Pharmacol; 2010 Feb; 79(3):321-9. PubMed ID: 19737543
[TBL] [Abstract][Full Text] [Related]
15. Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions.
Szczypka M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854348
[TBL] [Abstract][Full Text] [Related]
16. β-Adrenergic cAMP signals are predominantly regulated by phosphodiesterase type 4 in cultured adult rat aortic smooth muscle cells.
Zhai K; Hubert F; Nicolas V; Ji G; Fischmeister R; Leblais V
PLoS One; 2012; 7(10):e47826. PubMed ID: 23094097
[TBL] [Abstract][Full Text] [Related]
17. Use of a Schizosaccharomyces pombe PKA-repressible reporter to study cGMP metabolising phosphodiesterases.
Demirbas D; Ceyhan O; Wyman AR; Ivey FD; Allain C; Wang L; Sharuk MN; Francis SH; Hoffman CS
Cell Signal; 2011 Mar; 23(3):594-601. PubMed ID: 21118717
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
Sharma H; Lather V; Grewal AS; Pandita D
Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
